.RESEARCH EMPHASIZE.16 Oct 2024. In the NIAGARA litigation, the enhancement of perioperative durvalumab to basic procedure for muscle-invasive bladder cancer cells enhanced event-free as well as generally survival, marking a brand-new therapy alternative for this disorder.